220 Malincentives and Internal Profit Shifts: A 20-Year Financial Analysis of Major Health Insurers

View at publisher Summarise with VIRAT
Authors: Campbell Liles, Austin Michael Hilvert, Anthony E. Bishay, John Edwards Dugan, Robert J. Dambrino, Raymond Joseph Gardocki, Alexander Arash Khalessi, Lola Blackwell Chambless, Brian Rothman
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Since the Affordable Care Act’s (ACA) Medical Loss Ratio (MLR) requirement capped insurance-segment profits, major health insurers have vertically integrated to become the country’s largest physician employers with unexplored, potentially wasteful side-effects for US healthcare. METHODS: Analysis of Annual 10-K financial statements of the largest commercial health insurers (UnitedHealth, CVS/Aetna, Elevance, Humana, and Cigna) from 2003-2023. RESULTS: Major insurers cover 60% of the US with revenues exceeding $1.2 Trillion. Non-insurance segment profits rose from 8% to 50% of insurance profits post-ACA. 20.5% ($244.2 Billion) of noninvestment revenues flowed between major insurer segments (intersegmental sales) in 2023, compared to 2.2% ($2.1 Billion) in 2003. 95% of intersegment sales occurred post-ACA and 98.8% flowed toward non-insurance segments. Post-ACA, rising intersegment sales are significantly correlated with rising non-insurance profit margins (rs = 0.700, p < 0.001) and falling insurance segment profit margins (rs = -0.513, p < 0.001). One-year delays for external treatment and reimbursement earn insurers a risk-free 8.8% return after combining investments/inflation. Insurers are highly reliant on government-backed insurance (e.g., Medicare and Medicaid Advantage), comprising 70.1% of 2023 insurance segment revenues. CONCLUSIONS: This is the first analysis demonstrating major insurers’ may be systematically shifting profits from MLR-capped insurance segments toward uncapped non-insurance segments at high, undisclosed internal prices. This transfer is evidenced by massive, previously undescribed intersegmental sales toward non-insurance segments, and by inverse correlations between intersegmental sales and insurance segment profit margins post-ACA, which should be stable if intersegmental sales occurred at market or better prices. We also demonstrate heavy financial incentives to deny/delay external healthcare. Because these companies are increasingly dependent on public funding, greater public oversight is needed and regulators should require transparent reporting of internal versus external pricing, approval rates, and financial flows within each insurer.

Fields of Study & Subjects

Healthcare Policy and Management Insurance and Financial Risk Management Healthcare Systems and Reforms

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
49–49
Publication date
26 March 2026
Language
EN